E-LIB Suche - Ergebnisse für: Benardeau, Agnes

1

The sGC Activator Runcaciguat Has Kidney Protective Effects..:

Kraehling, Jan R. ; Benardeau, Agnes ; Schomber, Tibor...
International Journal of Molecular Sciences. 24 (2023) 17 - p. 13226 , 2023

Link: https://doi.org/10.3390/..

2

Urinary miRNA Profiles in Chronic Kidney Injury—Benefits of..:

Petzuch, Barbara ; Bénardeau, Agnès ; Hofmeister, Lucas...
Toxicological Sciences. 187 (2022) 1 - p. 35-50 , 2022

Link: https://doi.org/10.1093/..

3

Discovery of the Soluble Guanylate Cyclase Activator Runcac..:

Hahn, Michael G. ; Lampe, Thomas ; El Sheikh, Sherif...
Journal of Medicinal Chemistry. 64 (2021) 9 - p. 5323-5344 , 2021

Link: https://doi.org/10.1021/..

4

Novel soluble guanylyl cyclase activators increase glomerul..:

Stehle, Daniel ; Xu, Min Ze ; Schomber, Tibor...
British Journal of Pharmacology. 179 (2021) 11 - p. 2476-2489 , 2021

Link: https://doi.org/10.1111/..

5

Runcaciguat, a novel soluble guanylate cyclase activator, s..:

Bénardeau, Agnès ; Kahnert, Antje ; Schomber, Tibor...
Naunyn-Schmiedeberg's Archives of Pharmacology. 394 (2021) 12 - p. 2363-2379 , 2021

Link: https://doi.org/10.1007/..

6

The Impact of the Nitric Oxide (NO)/Soluble Guanylyl Cyclas..:

Krishnan, Shalini ; Kraehling, Jan ; Eitner, Frank..
International Journal of Molecular Sciences. 19 (2018) 6 - p. 1712 , 2018

Link: https://doi.org/10.3390/..

7

Animal Models of Diabetic Macrovascular Complications: Key ..:

Heinonen, Suvi E. ; Genové, Guillem ; Bengtsson, Eva...
Journal of Diabetes Research. 2015 (2015) - p. 1-14 , 2015

Link: https://doi.org/10.1155/..

8

Effects of pioglitazone and fenofibrate co-administration o..:

Smith, Susan Y. ; Samadfam, Rana ; Chouinard, Luc...
Journal of Bone and Mineral Metabolism. 33 (2014) 6 - p. 625-641 , 2014

Link: https://doi.org/10.1007/..

9

6-Alkoxy-5-aryl-3-pyridinecarboxamides, a New Series of Bio..:

Röver, Stephan ; Andjelkovic, Mirjana ; Bénardeau, Agnès...
Journal of Medicinal Chemistry. 56 (2013) 24 - p. 9874-9896 , 2013

Link: https://doi.org/10.1021/..

10

Effects of aleglitazar, a balanced dual peroxisome prolifer..:

Hansen, Barbara C ; Tigno, Xenia T ; Bénardeau, Agnes...
Cardiovascular Diabetology. 10 (2011) 1 - p. 7 , 2011

Link: https://doi.org/10.1186/..

11

Orally active aminopyridines as inhibitors of tetrameric fr..:

Hebeisen, Paul ; Haap, Wolfgang ; Kuhn, Bernd...
Bioorganic & Medicinal Chemistry Letters. 21 (2011) 11 - p. 3237-3242 , 2011

Link: https://doi.org/10.1016/..

12

Sulfonylureido thiazoles as fructose-1,6-bisphosphatase inh..:

Kitas, Eric ; Mohr, Peter ; Kuhn, Bernd...
Bioorganic & Medicinal Chemistry Letters. 20 (2010) 2 - p. 594-599 , 2010

Link: https://doi.org/10.1016/..

13

Design and Biological Evaluation of Novel, Balanced Dual PP..:

Grether, Uwe ; Bénardeau, Agnes ; Benz, Jörg...
ChemMedChem. 4 (2009) 6 - p. 951-956 , 2009

Link: https://doi.org/10.1002/..

14

Inside Cover: Design and Biological Evaluation of Novel, Ba..:

Grether, Uwe ; Bénardeau, Agnes ; Benz, Jörg...
ChemMedChem. 4 (2009) 6 - p. 886-886 , 2009

Link: https://doi.org/10.1002/..

15

Aleglitazar, a new, potent, and balanced dual PPARα/γ agoni..:

Bénardeau, Agnes ; Benz, Jörg ; Binggeli, Alfred...
Bioorganic & Medicinal Chemistry Letters. 19 (2009) 9 - p. 2468-2473 , 2009

Link: https://doi.org/10.1016/..